id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2013-N-1428-0022,FDA,FDA-2013-N-1428,"Agency Information Collection Activities; Submission for Office of
Management and Budget Review; Comment Request; Electronic Drug
Product Reporting for Human Drug Compounding Outsourcing Facilities
Under Section 503B of the Federal Food, Drug, and Cosmetic Act",Notice,30 Day Proposed Information Collection,2019-10-10T04:00:00Z,2019,10,2019-10-10T04:00:00Z,2019-11-13T04:59:59Z,2019-10-10T14:02:43Z,2019-22189,0,0,090000648407778c
FDA-2013-N-1428-0021,FDA,FDA-2013-N-1428,"Agency Information Collection Activities; Proposed Collection; Comment Request; Electronic Drug Product Reporting for Human Drug Compounding Outsourcing Facilities Under Section 503B of the Federal Food, Drug, and Cosmetic Act",Notice,60 Day Proposed Information Collection,2019-07-17T04:00:00Z,2019,7,2019-07-17T04:00:00Z,2019-09-17T03:59:59Z,2019-07-17T12:25:22Z,2019-15124,0,0,0900006483d98dc0